Search for:

In brief

In the current narcotics and psychotropic substances regulatory regime, there are numerous laws governing narcotics and psychotropic substances which are enforced by different regulatory bodies. The Thai government aims to modernize certain current provisions and to incorporate these laws into the Narcotics Code for ease of reference and consistency in law enforcement. 


  1. In more detail

In more detail

Earlier this month, the Narcotics Code was published in the Government Gazette. The Narcotics Code will be effective on 10 December 2021 and will become the overarching legal framework regulating narcotics and psychotropic substances in Thailand.

Generally speaking, the regulations on narcotics, including cannabis and hemp, under the Narcotics Code are largely in line with those under the current laws on narcotics and psychotropic substances that will be repealed by the Narcotics Code when the Code becomes effective. All the current sub-regulations that were issued under the current laws on narcotics and psychotropic substances, including those on the categorization of narcotics, will remain in force to the extent that they do not conflict with or contradict the Narcotics Code or until the sub-regulations under the Narcotics Code are issued.

For more information, please contact our Healthcare & Life Sciences Industry Group at Baker McKenzie.


Peerapan Tungsuwan is a corporate and M&A partner in Bangkok office with specialties in highly regulated industries, including the healthcare industry. She is currently Chair of the AEC Healthcare Harmonization Sub-committee of Baker McKenzie's Asia Pacific Healthcare Industry Group, of which she was head from 2007-2013. Within the Bangkok office, she heads the Healthcare Industry and Natural Resources Groups and co-leads the Mergers & Acquisitions practice group and Japan Advisory Group.


Panyavith assists major local and multinational clients in a range of heavily regulated industries, such as healthcare & life sciences, chemical and biotech, on large complex mergers and acquisitions, private equity transactions, joint ventures, corporate restructurings, post-acquisition integration projects, commercial agreements and regulatory issues. With his technical and commercial astute, Panyavith has often been involved in a number of pioneering projects, helping clients navigate the challenges of uncharted waters and emerging opportunities with innovative solutions. He is recently recognized as "Up and Coming for Corporate and M&A" in Thailand by Chambers Asia-Pacific 2023.


Prim Uditananda is a Regulatory Affairs Manager in Baker McKenzie, Bangkok office.


Parisa Nontasirichayakul is an Associate in Baker McKenzie Bangkok office.

Write A Comment